-
Jan 12, 2015, 09:00 AM
by
Michael Croft
Bio-IT World | Roche announced this morning that it has acquired a majority stake in Foundation Medicine. Roche will tender approximately $780m for 56.3% of the company.
Full story
-
Jan 12, 2015, 00:00 AM
by
Michael Croft
BostonGlobe.com | These are boom times in
biotechnology. Forty-one new drugs were approved for US sale in
2014, the highest tally in 18 years. A record 63 biotech startups
went public, breaking the 1999 record of 52 initial public
offerings. And the value of biopharma merger deals nearly tripled
to $223 billion from a year earlier.
Full story
-
Jan 12, 2015, 00:00 AM
by
Michael Croft
Bloomberg | 23andMe Inc., the genetic-testing
startup backed by Google Inc., is sharing DNA data on about 650,000
individuals with Pfizer Inc., to help find new targets to treat
disease and to design clinical trials.
Full story
-
Jan 12, 2015, 00:00 AM
by
Michael Croft
CALIFORNIA, CA, UNITED STATES - Jan 12, 2015 - The report firstly introduced Prokaryotic Expression Systems Market basic information including Prokaryotic Expression Systems Market definition, classification, application and Market chain overview; Prokaryotic Expression Systems Market policy and plan, Prokaryotic Expression Systems product specification, manufacturing process, cost structure etc
Full story
-
Jan 12, 2015, 00:00 AM
by
Michael Croft
Boston Business Journal | The Cambridge biotech
firm, known best for its drugs for multiple sclerosis, announced
the acquisition of Convergence Pharmaceuticals.
Full story
-
Jan 12, 2015, 00:00 AM
by
Michael Croft
HARDERWIJK, THE NETHERLANDS - Jan 12, 2015 - Today
GENALICE and Knome, Inc. USA jointly announced a strategic
partnership to offer their products together as a turn-key solution
for those using next-generation sequencing (NGS) data to interpret
patients' genomes
Full story
-
Jan 9, 2015, 14:00 PM
by
Michael Croft
Bio-IT World | WuXi PharmaTech headquartered in Shanghai has acquired NextCODE Health of Iceland for $65 million in cash. The acquisition will merge the WuXi Genome Center with NextCODE to form WuXi NextCODE Genomics.
Full story
-
Jan 9, 2015, 00:00 AM
by
Michael Croft
NEW YORK, NY, UNITED STATES - Jan 9, 2015 - CAMBRIDGE,
MA, and NEW YORK, NY (January 9, 2015) - Biogen Idec
(NASDAQ: BIIB) and Columbia University Medical
Center have formed a $30 million strategic alliance to
conduct genetics discovery research on the underlying causes of
disease and to identify new treatment approaches
Full story
-
Jan 8, 2015, 10:00 AM
by
Michael Croft
Forbes | 2014 saw the highest number of new drug applications approved by FDA since 1996, but John LaMattina argues that the year was even more successful than that.
Full story
-
Jan 8, 2015, 09:00 AM
by
Michael Croft
New York Times | Researchers yesterday announced a new antibiotic found in dirt. Teixobactin has not been tested in humans, but was extremely effective in animal tests.
Full story
-
Jan 8, 2015, 00:00 AM
by
Michael Croft
DUBLIN, IRELAND - Jan 8, 2015 - CLIRINX Ltd. announced today that it has launched a new web-based platform for clinical research. The software allows researchers manage their studies and collect medical research data using a sophisticated, web-based system
Full story
-
Jan 7, 2015, 14:30 PM
by
Michael Croft
Bio-IT World | Novartis today became the first big pharma company to announce a CRISPR program, through a deal with Intellia Therapeutics and Caribou Biosciences that will cover CAR-T therapies and hematopoietic stem cell programs.
Full story
-
Jan 7, 2015, 11:15 AM
by
Michael Croft
Bio-IT World | The $1,000 genome, CRISPR gene therapies, nanopore sequencing, the fall of 23andMe's health service... we look back at six of our most popular stories of 2014, and reflect on how each has developed since.
Full story
-
Jan 7, 2015, 09:00 AM
by
Michael Croft
Bio-IT World Roundup | Moderna Therapeutics closed a massive private investment round earlier this week, raising $450 million bringing their total funding to $950 million.
Full story
-
Jan 6, 2015, 13:50 PM
by
Michael Croft
Forbes | 23andMe has signed a deal with Genentech to sequence the whole genomes of 3,000 Parkinson's patients and relatives in its customer community, sharing both genetic and clinical data with the big biotech.
Full story
-
Jan 6, 2015, 10:00 AM
by
Michael Croft
Bio-IT World | David Mittelman, co-founder of Arpeggi and GCAT, the Genomics Comparison and Analytic Testing (GCAT) platform, has joined Tute Genomics as CSO.
Full story
-
Jan 6, 2015, 00:00 AM
by
Michael Croft
COLUMBIA AND BETHESDA, MD - Jan 6, 2015 - Columbia, MD
and Bethesda, MD - January 6, 2015 - TEMIS,
the leading provider of Semantic Content Enrichment solutions for
the Enterprise, today announced an extension of their collaboration
with the American Society for Cell Biology (ASCB) to further hone
the ASCB Science Navigator, a bespoke version of TEMIS Luxid®
Navigator - Biopharma Edition, as a tool for biomedical
research
Full story
-
Jan 5, 2015, 10:55 AM
by
Michael Croft
FierceBiotech | Spark Therapeutics, a company with a strong Phase III drug candidate bidding to be the first gene therapy approved for use in the U.S., has filed for an IPO, planning to sell $86 million in public shares.
Full story
-
Jan 5, 2015, 10:30 AM
by
Michael Croft
Reuters | In advance of a final decision to be handed down January 7, the FDA today revealed that staff reviewers have recommended approval of a biologic made by Novartis that imitates Amgen's off-patent Neupogen.
Full story
-
Jan 2, 2015, 11:20 AM
by
Michael Croft
Bio-IT World | Looking to open its highly sensitive Simoa instruments to new customers, Quanterix is opening an accelerator in its Massachusetts lab, where users can test out homebrewed assays in search of new biomarker tests that detect proteins at extremely low concentrations.
Full story